2 completed, 2 not yet recruiting, 1 terminated, 1 unknown. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Not yet recruiting 2, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow BEAM: new trials by email Literature Review of BEAM trials Research Report on BEAM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive selinexor combined with BEAM regimen, BEAM regimen - Diffuse Large B Cell Lymphoma | Phase 2 | Not yet recruiting | Ruijin Hospital | 82 | 2024-11-01 | 2024-10-22 |
| Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL zanubrutinib combined with BEAM, BEAM - DLBCL | Phase 2 | Not yet recruiting | Ruijin Hospital | 66 | 2024-11-01 | 2024-10-22 |
| A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial) BeEAM, BEAM - Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 108 | 2015-04-01 | 2025-08-01 |
| Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma Auto stem cell transplant, BEAM, 111In-daclizumab - Hodgkin Disease, Hodgkin Lymphoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 6 | 2011-10-11 | 2021-10-06 |
| Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma | Phase 2 | Unknown | Heidelberg University | 20 | 2004-07-01 | 2009-07-27 |
| Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma Rituxan, BEAM, Autologous stem cell transplant - Lymphoma | Phase 1 / Phase 2 | Completed | University of Nebraska | 32 | 1998-05-12 | 2023-09-07 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Mantle-Cell (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Ruijin Hospital (2) · Heidelberg University (1) · Insel Gruppe AG, University Hospital Bern (1) · National Cancer Institute (NCI) (1) · University of Nebraska (1)
United States (2) · Austria (1) · Germany (1) · Switzerland (1)
Anthony D. Ho, Ph.D., Prof. (1) · Felix Keil, Prim. Univ. Prof. Dr (1) · Julie M Vose, MD (1) · Kevin C Conlon, M.D. (1) · Thomas Pabst, Prof Dr. med (1)
PMID 10673703, PMID 21816830, PMID 23749106, PMID 24591201, PMID 38024477, PMID 7477169
2014 (1)